HuGE Literature Finder
Records 1-5
Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment.
Translational research : the journal of laboratory and clinical medicine 2012 Oct 160 (4): 298-308. Trdan Lušin Tina, Mrhar Aleš, Stieger Bruno, Kullak-Ublick Gerd A, Marc Janja, Ostanek Barbara, Zavratnik Andrej, Kristl Albin, Berginc Katja, Deli? Katja, Trontelj Jur |
Study of ABCB1 polymorphism frequency in breast cancer patients from Poland.
Pharmacological reports : PR 2012 64 (6): 1560-6. Rubi? B?a?ej, Ho?ysz Hanna, Barczak Wojciech, Gryczka Robert, ?aci?ski Mariusz, Jagielski Pawe?, Czernikiewicz Anna, Pó?rolniczak Anna, Wojewoda Aneta, Perz Katarzyna, Bia?ek Pawe?, Morze Karolina, Kandu?a Zuzanna, Lisiak Natalia, Mrozikiewicz Przemys?aw M, Grodecka-Gazdecka Sylwia, Rybczy?ska Mar |
MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome.
The pharmacogenomics journal 2010 Feb 10 (1): 62-9. Cizmarikova M, Wagnerova M, Schonova L, Habalova V, Kohut A, Linkova A, Sarissky M, Mojzis J, Mirossay L, Mirossay |
Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population.
DNA and cell biology 2009 May 28 (5): 259-63. Tatari Farnoosh, Salek Roham, Mosaffa Fatemeh, Khedri Azam, Behravan Jav |
MDR1 C3435T polymorphism in patients with breast cancer.
Archives of medical research 2007 Jul 38 (5): 539-44. Turgut Sebahat, Yaren Arzu, Kursunluoglu Raziye, Turgut Günf |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: